| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/01/2009 | US20090004285 Stable non-disintegrating dosage forms and method of making same |
| 01/01/2009 | US20090004284 Controlled release tamsulosin hydrochloride formulation |
| 01/01/2009 | US20090004282 Method of Particle Formation |
| 01/01/2009 | US20090004281 Multiparticulate osmotic delivery system |
| 01/01/2009 | US20090004280 kit for caring for the skin intended to soften cutaneous signs of ageing |
| 01/01/2009 | US20090004279 Method For Improvement Of Tolerance For Therapeutically Effective Agents Delivered By Inhalation |
| 01/01/2009 | US20090004277 Nanoparticle dispersion containing lactam compound |
| 01/01/2009 | US20090004271 Morselized foam for wound treatment |
| 01/01/2009 | US20090004269 Pharmaceutical Composition Comprising a Proton Pump Inhibitor and a Protein Component |
| 01/01/2009 | US20090004268 Methods and Compositions for Treatment of an Interstitial Lung Disease |
| 01/01/2009 | US20090004265 Prevention and Treatment of Thromboembolic Disorders |
| 01/01/2009 | US20090004263 Modified release preparations containing oxcarbazepine and derivatives thereof |
| 01/01/2009 | US20090004261 Pharmaceutical composition for oral administration of a pyrazole-3-carboxamide derivative |
| 01/01/2009 | US20090004260 Medicament comprising hgf gene |
| 01/01/2009 | US20090004257 Transdermal administration of fentanyl and analogs thereof |
| 01/01/2009 | US20090004255 Adhesive patch for external use with improved cohesive force and sustained-release characteristics |
| 01/01/2009 | US20090004253 Composite device for the repair or regeneration of tissue |
| 01/01/2009 | US20090004249 Dual release nicotine formulations, and systems and methods for their use |
| 01/01/2009 | US20090004248 Dual portion dosage lozenge form |
| 01/01/2009 | US20090004247 Novel substance derived from basidiomycetes culture, method for producing it and its use |
| 01/01/2009 | US20090004243 Biodegradable triblock copolymers for implantable devices |
| 01/01/2009 | US20090004241 Polymer nanofilm coatings |
| 01/01/2009 | US20090004240 Implants with a phosphazene-containing coating |
| 01/01/2009 | US20090004237 B7-Like Molecules and Uses Thereof |
| 01/01/2009 | US20090004235 Methods of Accelerating Muscle Growth, Decreasing Fat Deposits and Improving Feed Efficiency in Livestock Animals |
| 01/01/2009 | US20090004233 Microencapsulating compositions, methods of making, methods of using and products thereof |
| 01/01/2009 | US20090004232 Bioactive pharmaceutical/cosmetic compositions and mixed solubilization process for the formulation thereof |
| 01/01/2009 | US20090004229 rupturing controlled release device comprising a subcoat |
| 01/01/2009 | US20090004220 Compositions of Plant Carbohydrates as Dietary Supplements |
| 01/01/2009 | US20090004209 4'-O- substituted isoindoline derivatives and compositions comprising and methods of using the same |
| 01/01/2009 | US20090004208 Method for designing hypoallergenic molecules for use in allergy desensitization with lessened chance of anaphylaxis, or as vaccines against allergic reactions |
| 01/01/2009 | US20090004207 Methods and Compositions for Inhibiting Pathological Angiogenesis in the Eye |
| 01/01/2009 | US20090004206 Polynucleotides and Polypeptide Sequences Involved in the Process of Bone Remodeling |
| 01/01/2009 | US20090004203 Methods of treating measles infectious disease in mammals |
| 01/01/2009 | US20090004202 Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin |
| 01/01/2009 | US20090004201 Therapy-Enhancing Glucan |
| 01/01/2009 | US20090004200 Combination treatment of pancreatic cancer |
| 01/01/2009 | US20090004197 Dek Protein Compositions and Methods of Using the Same |
| 01/01/2009 | US20090004195 Somatostatin receptor antagonists and glucose control or hypoglycemia |
| 01/01/2009 | US20090004193 Diagnostics and Therapeutics for Diseases Associated With Vasoactive Intestinal Peptide Receptor 1 (Vpac1) |
| 01/01/2009 | US20090004191 Expansion of Stem/Progenitor Cells by Inhibition of Enzymatic Reactions Catalyzed by the Sir2 Family of Enzymes |
| 01/01/2009 | US20090004187 Polymorphism in the apo(a) gene predict responsiveness to acetylsalicylic acid treatment (ridker) |
| 01/01/2009 | US20090004185 Amino-substituted quinazoline derivatives as inhibitors of beta-catenin/tcf-4 pathway and cancer treatment agents |
| 01/01/2009 | US20090004173 Diagnosis and Treatment of Drug Resistant Leukemia |
| 01/01/2009 | US20090004172 Service for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using erp57 translocation |
| 01/01/2009 | US20090004170 Composition comprising coenzyme q10 |
| 01/01/2009 | US20090004169 Nucleic Acids For Inhibiting Hairless Protein Expression and Methods of Use Thereof |
| 01/01/2009 | US20090004168 Health Enhancement System |
| 01/01/2009 | US20090004166 Carrier For Enternal Administration |
| 01/01/2009 | US20090004162 Hecgf-1 Related Polymorphisms and Applications Thereof |
| 01/01/2009 | US20090004158 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 01/01/2009 | US20090004156 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNalpha17 GENE |
| 01/01/2009 | US20090004145 Compositions and methods involving gene therapy and proteasome modulation |
| 01/01/2009 | US20090004143 Treatment of diseases caused by viral infection |
| 01/01/2009 | US20090004140 4-substituted pyrrolidine as anti-infectives |
| 01/01/2009 | US20090004139 Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly |
| 01/01/2009 | US20090004138 Bicyclic Nucleosides and Nucleotides as Therapeutic Agents |
| 01/01/2009 | US20090004137 Uridine Derivatives as Antiviral Drugs Against a Flaviviridae, Especially Hcv |
| 01/01/2009 | US20090004136 administering to a cancer patients, heterocyclic trialkyl ammonium-compounds such as [3-(3,4-dimethyl-9-oxo-9H-thioxanthen-2-yloxy)-2-hydroxypropyl]trimethylammonium chloride, to normalize blood cell and platelet counts and to reduce side effects of radiotherapy and chemotherapy |
| 01/01/2009 | US20090004135 Modified fluorinated nucleoside analogues |
| 01/01/2009 | US20090004134 Kit for treating a health condition by inducing translocation of an erp57 protein to a cellular membrane |
| 01/01/2009 | US20090004133 Methods and compositions for phosphate binding |
| 01/01/2009 | US20090004125 Dispersions of polymers in organic medium, and compositions comprising them |
| 01/01/2009 | US20090004122 Skin and surface disinfectant compositions containing botanicals |
| 01/01/2009 | US20090004121 Combination of picotamide with nafronyl |
| 01/01/2009 | US20090004118 Multifunctional Nanoparticle Conjugates And Their Use |
| 01/01/2009 | US20090004112 Methods for the treatment of neurodegenerative diseases using nmda receptor glycine site antagonists |
| 01/01/2009 | US20090004104 Methods and Compositions for Delivering Active Agents with Enhanced Pharmacological Properties |
| 01/01/2009 | US20090004103 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 01/01/2009 | US20090004101 Method and Means for Enhanced Pulmonary Drug Delivery |
| 12/31/2008 | WO2009003199A1 Nasal and ophthalmic delivery of aqueous corticosteroid solutions |
| 12/31/2008 | WO2009003164A1 Compositions comprising indoleamine 2,3- dioxygenase-2 and coenzyme q inhibitors and methods of use thereof |
| 12/31/2008 | WO2009003136A1 Substituted pyrimidine-2, 4 -diamines for treating cell proliferative disorders |
| 12/31/2008 | WO2009003090A2 Compositions and methods for inhibiting viral and bacterial activity |
| 12/31/2008 | WO2009003077A1 Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function |
| 12/31/2008 | WO2009003075A1 Animal pest control method |
| 12/31/2008 | WO2009003062A1 Methods of performing minimally invasive surgery |
| 12/31/2008 | WO2009003017A1 Curing accelerator and method of making |
| 12/31/2008 | WO2009003009A1 Substituted pyrrolidine as anti-infectives |
| 12/31/2008 | WO2009003001A2 Preparation of risedronate sodium hemi-pentahydrate |
| 12/31/2008 | WO2009002982A2 Gastropod biological fluid, method of making and refining and use |
| 12/31/2008 | WO2009002977A1 Salacia cuspidata extract and methods of extracting and using such extract |
| 12/31/2008 | WO2009002970A1 Compositions comprising tryptophan hydroxylase inhibitors |
| 12/31/2008 | WO2009002964A1 Methods of treating serotonin-mediated diseases and disorders |
| 12/31/2008 | WO2009002944A1 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 12/31/2008 | WO2009002941A1 Composition and method for the treatment of diseases affected by histone deacetylase inhibitors |
| 12/31/2008 | WO2009002935A1 Transdermal delivery system comprising glycopyrrolate to treat sialorrhea |
| 12/31/2008 | WO2009002933A1 Methods and compositions for treating disorders |
| 12/31/2008 | WO2009002923A1 Substituted pyrrolidine compounds with central nervous system activity |
| 12/31/2008 | WO2009002922A2 Single dose roxithromycin |
| 12/31/2008 | WO2009002913A1 Use of creatine compounds to treat dermatitis |
| 12/31/2008 | WO2009002873A1 Compounds, compositions and methods for reducing lipid levels |
| 12/31/2008 | WO2009002870A1 Methods for treating aberrant cell proliferation disorders |
| 12/31/2008 | WO2009002838A1 Methods for treating ophthalmic disorders |
| 12/31/2008 | WO2009002829A2 Tableted compositions containing atazanavir |
| 12/31/2008 | WO2009002826A2 Tableted compositions containing atazanavir |
| 12/31/2008 | WO2009002823A2 Tableted compositions containing atazanavir |
| 12/31/2008 | WO2009002821A2 Tableted compositions containing atazanavir |
| 12/31/2008 | WO2009002808A2 Quinazolinone compounds and methods of use thereof |
| 12/31/2008 | WO2009002807A2 Indolyl pyrrolidines for the treatment of cancer |